After baicalein treatment, the expression of β-catenin and target gene proteins (cyclinD1, c-myc, survivin) in tumor tissue decreased significantly, indicating that the potential molecular mechanism might be through inhibiting the Wnt/β-catenin signaling pathway (Figure 7). This evidence concerns the gene BIRC5 and neoplasm.